Immunovant, Inc. · NASDAQ:IMVT
Van Tuyl Christopher sold 1,206 Immunovant, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Van Tuyl Christopher (Chief Legal Officer) sold 1,206 Immunovant, Inc. shares at an average US$39.55 for US$47,702, leaving 179,391 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 1,206 shares
- Price
- US$39.55 average (US$39.53 to US$39.99)
- Value
- US$47,702
- Holding after
- 179,391 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Sale | 1,143 | US$39.53 | 179,454 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 63 | US$39.99 | 179,391 | Direct |
Source
Related
- Immunovant, Inc.
- Van Tuyl Christopher
- Immunovant, Inc. shareholders
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Van Tuyl Christopher · Jun 26, 2026
- Form 4 · Van Tuyl Christopher · Jun 22, 2026
- Form 4 · Van Tuyl Christopher · Apr 10, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Pande Atul · Aug 28, 2026
- Form 4 · Gloria Melanie · Aug 21, 2026